Health Insurance Companies and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Health Insurance Companies

Pharmaceuticals

Overcoming Healthcare’s Mountain of Mistrust – Part 2: Payers

Perficient: Drug Development

JANUARY 25, 2024

To recap: Part 1 of the series focused on providers This part, Part 2, focuses on payers (insurance companies) Part 3 (by Marlana Voerster ) will focus on medical-device organizations First off: the bad news in trust for payers Gallup’s polling data among U.S. Quite frankly … not much. So there’s not much to celebrate in these results.

Nurses

Nurses Health Insurance Companies Pharmaceutical Companies Hospitals

Combo ‘Polypill’ May Cut Heart Attack, Stroke Risk Up to 40%

The Pharma Data

NOVEMBER 16, 2020

Yang pointed out that “the fact that it’s generic is a double-edged sword, because no big pharma company is willing to invest a lot of money in developing and marketing a polypill. It may require either health insurance companies or governments or charitable organizations to develop polypills.”

Health Insurance Companies

Health Insurance Companies Doctors Medical Schools Pharma Companies

Drug Discovery Digest

Overcoming Healthcare’s Mountain of Mistrust – Part 2: Payers

Combo ‘Polypill’ May Cut Heart Attack, Stroke Risk Up to 40%

Stay Connected